GLUE
Price
$4.92
Change
+$0.01 (+0.20%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
303.24M
62 days until earnings call
ITRM
Price
$0.68
Change
+$0.05 (+7.94%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
28.22M
63 days until earnings call
Interact to see
Advertisement

GLUE vs ITRM

Header iconGLUE vs ITRM Comparison
Open Charts GLUE vs ITRMBanner chart's image
Monte Rosa Therapeutics
Price$4.92
Change+$0.01 (+0.20%)
Volume$1.64K
Capitalization303.24M
Iterum Therapeutics
Price$0.68
Change+$0.05 (+7.94%)
Volume$12.6K
Capitalization28.22M
GLUE vs ITRM Comparison Chart in %
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. ITRM commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a StrongBuy and ITRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GLUE: $4.91 vs. ITRM: $0.63)
Brand notoriety: GLUE and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 65% vs. ITRM: 38%
Market capitalization -- GLUE: $303.24M vs. ITRM: $28.22M
GLUE [@Biotechnology] is valued at $303.24M. ITRM’s [@Biotechnology] market capitalization is $28.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than ITRM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 5 TA indicator(s) are bullish while ITRM’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 5 bullish, 5 bearish.
  • ITRM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than ITRM.

Price Growth

GLUE (@Biotechnology) experienced а +1.66% price change this week, while ITRM (@Biotechnology) price change was -8.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

GLUE is expected to report earnings on Nov 06, 2025.

ITRM is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($303M) has a higher market cap than ITRM($28.2M). GLUE YTD gains are higher at: -29.251 vs. ITRM (-64.294). GLUE has higher annual earnings (EBITDA): 23.3M vs. ITRM (-20.51M). GLUE has more cash in the bank: 291M vs. ITRM (13M). ITRM has less debt than GLUE: ITRM (32.6M) vs GLUE (41.1M). GLUE has higher revenues than ITRM: GLUE (178M) vs ITRM (0).
GLUEITRMGLUE / ITRM
Capitalization303M28.2M1,074%
EBITDA23.3M-20.51M-114%
Gain YTD-29.251-64.29445%
P/E Ratio12.59N/A-
Revenue178M0-
Total Cash291M13M2,238%
Total Debt41.1M32.6M126%
FUNDAMENTALS RATINGS
ITRM: Fundamental Ratings
ITRM
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEITRM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 19 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMAB103.181.17
+1.15%
Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
TDG1281.813.33
+0.26%
TransDigm Group
MDXG7.09-0.01
-0.14%
MiMedx Group
VEEA0.54-0.02
-2.89%
Veea Inc
BZUN3.86-0.17
-4.22%
Baozun

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.80%
EYPT - GLUE
48%
Loosely correlated
-1.00%
NRIX - GLUE
40%
Loosely correlated
-3.59%
ITRM - GLUE
40%
Loosely correlated
+0.48%
FATE - GLUE
39%
Loosely correlated
-2.71%
IMNM - GLUE
39%
Loosely correlated
-4.39%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with GLUE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
+0.48%
GLUE - ITRM
40%
Loosely correlated
-1.80%
ACRS - ITRM
34%
Loosely correlated
+0.49%
TARA - ITRM
31%
Poorly correlated
-1.86%
IBRX - ITRM
26%
Poorly correlated
+0.84%
ANAB - ITRM
25%
Poorly correlated
-6.39%
More